Astrazeneca Plc Adr Stock Probability of Future Stock Price Finishing Over 64.26
| AZN Stock | USD 64.26 1.06 1.68% |
AstraZeneca |
AstraZeneca PLC Target Price Odds to finish over 64.26
The tendency of AstraZeneca Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 64.26 | 90 days | 64.26 | roughly 96.0 |
Based on a normal probability distribution, the odds of AstraZeneca PLC to move above the current price in 90 days from now is roughly 96.0 (This AstraZeneca PLC ADR probability density function shows the probability of AstraZeneca Stock to fall within a particular range of prices over 90 days) .
Considering the 90-day investment horizon AstraZeneca PLC ADR has a beta of -0.14. This suggests as returns on the benchmark increase, returns on holding AstraZeneca PLC are expected to decrease at a much lower rate. During a bear market, however, AstraZeneca PLC ADR is likely to outperform the market. Additionally AstraZeneca PLC ADR has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. AstraZeneca PLC Price Density |
| Price |
Predictive Modules for AstraZeneca PLC
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as AstraZeneca PLC ADR. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.AstraZeneca PLC Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. AstraZeneca PLC is not an exception. The market had few large corrections towards the AstraZeneca PLC's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold AstraZeneca PLC ADR, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of AstraZeneca PLC within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.44 | |
β | Beta against Dow Jones | -0.14 | |
σ | Overall volatility | 6.98 | |
Ir | Information ratio | -0.37 |
AstraZeneca PLC Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of AstraZeneca PLC for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for AstraZeneca PLC ADR can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| AstraZeneca PLC ADR generated a negative expected return over the last 90 days | |
| AstraZeneca PLC ADR has 28.62 B in debt with debt to equity (D/E) ratio of 0.89, which is OK given its current industry classification. AstraZeneca PLC ADR has a current ratio of 0.79, suggesting that it has not enough short term capital to pay financial commitments when the payables are due. Note however, debt could still be an excellent tool for AstraZeneca to invest in growth at high rates of return. | |
| AstraZeneca PLC ADR has a very strong financial position based on the latest SEC filings | |
| Latest headline from investing.com: astrazeneca non-executive director buys company shares |
AstraZeneca PLC Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of AstraZeneca Stock often depends not only on the future outlook of the current and potential AstraZeneca PLC's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. AstraZeneca PLC's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 3.1 B | |
| Cash And Short Term Investments | 5.9 B |
AstraZeneca PLC Technical Analysis
AstraZeneca PLC's future price can be derived by breaking down and analyzing its technical indicators over time. AstraZeneca Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of AstraZeneca PLC ADR. In general, you should focus on analyzing AstraZeneca Stock price patterns and their correlations with different microeconomic environments and drivers.
AstraZeneca PLC Predictive Forecast Models
AstraZeneca PLC's time-series forecasting models is one of many AstraZeneca PLC's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary AstraZeneca PLC's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about AstraZeneca PLC ADR
Checking the ongoing alerts about AstraZeneca PLC for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for AstraZeneca PLC ADR help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| AstraZeneca PLC ADR generated a negative expected return over the last 90 days | |
| AstraZeneca PLC ADR has 28.62 B in debt with debt to equity (D/E) ratio of 0.89, which is OK given its current industry classification. AstraZeneca PLC ADR has a current ratio of 0.79, suggesting that it has not enough short term capital to pay financial commitments when the payables are due. Note however, debt could still be an excellent tool for AstraZeneca to invest in growth at high rates of return. | |
| AstraZeneca PLC ADR has a very strong financial position based on the latest SEC filings | |
| Latest headline from investing.com: astrazeneca non-executive director buys company shares |
Check out AstraZeneca PLC Backtesting, AstraZeneca PLC Valuation, AstraZeneca PLC Correlation, AstraZeneca PLC Hype Analysis, AstraZeneca PLC Volatility, AstraZeneca PLC History as well as AstraZeneca PLC Performance. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of AstraZeneca PLC. If investors know AstraZeneca will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about AstraZeneca PLC listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.034 | Dividend Share 2.97 | Earnings Share 2.07 | Revenue Per Share 2.7424 | Quarterly Revenue Growth 0.18 |
The market value of AstraZeneca PLC ADR is measured differently than its book value, which is the value of AstraZeneca that is recorded on the company's balance sheet. Investors also form their own opinion of AstraZeneca PLC's value that differs from its market value or its book value, called intrinsic value, which is AstraZeneca PLC's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because AstraZeneca PLC's market value can be influenced by many factors that don't directly affect AstraZeneca PLC's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between AstraZeneca PLC's value and its price as these two are different measures arrived at by different means. Investors typically determine if AstraZeneca PLC is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, AstraZeneca PLC's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.